| Financial Year |
March 31 2023 |
| Monetary Funds |
346,046,878.71 |
| Held-for-trading Financial Assets |
149,919,987.45 |
| Notes Receivable |
2,978,896.98 |
| Accounts Receivable |
347,977,456.52 |
| Advances to Suppliers |
18,286,136.62 |
| Other Receivables |
9,018,496.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
251,274,981.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
225,822,417.26 |
| Total Current Assets |
1,367,909,028.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
260,043,606.86 |
| Under-construction Projects |
24,280,161.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,997,676.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,666,328.03 |
| Deferred Income Tax Assets |
25,572,322.17 |
| Other Non-Current Assets |
62,359,610.70 |
| Sub-Total of Non-Current Assets |
478,410,493.94 |
| Total Assets |
1,846,319,522.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
420,906.30 |
| Notes Payable |
41,010,000.00 |
| Accounts Payable |
216,156,462.47 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,025,116.97 |
| Taxes Payable |
10,675,877.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,474,078.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,905,939.34 |
| Other Current Liabilities |
13,194,566.19 |
| Sub-Total of Current Liabilities |
341,979,215.77 |
| Long-term Loans |
146,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,237,661.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
172,280,968.81 |
| Total Liabilities |
514,260,184.58 |
| Paid-In Capital(Or Share Stock) |
315,346,412.00 |
| Capital Surplus |
625,624,240.81 |
| Surplus Reserve |
62,670,037.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
315,061,458.86 |
| Minority Stockholder's Interest |
13,357,188.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,318,702,148.86 |
| Owner's Equity（Stockholder's Equity） |
1,332,059,337.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,846,319,522.40 |
